Who owns DIANTHUS THERAPEUTICS INC?
- Ticker: DNTH
- CUSIP Number: 252828108
Tip: Access positions for across all investors
Analyze quarterly positions in Dianthus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Dianthus Therapeutics stock
Who bought or sold DIANTHUS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 4.2M | $125M | 88% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 3.0M | $90M | 100% | Mar 2024 |
|
| Fairmount Funds Management | 2.8M | $83M | 43% | Mar 2024 |
|
| Avidity Partners Management | 2.7M | $82M | 123% | Mar 2024 |
|
| RA Capital Management | 2.3M | $70M | 100% | Mar 2024 |
|
| VR Adviser | 2.1M | $63M | 126% | Mar 2024 |
|
| Octagon Capital Advisors | 1.4M | $41M | 149% | Mar 2024 |
|
| 5AM Venture Management | 1.2M | $37M | -16% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 625k | $19M | 100% | Mar 2024 |
|
| Vanguard Group | 538k | $16M | 250% | Mar 2024 |
|
| Henderson Group | 375k | $11M | 100% | Mar 2024 |
|
| Point72 Asset Management | 352k | $11M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 298k | $8.9M | 100% | Mar 2024 |
|
| Millennium Management | 277k | $8.3M | 716% | Mar 2024 |
|
| Tang Capital Management | 265k | $7.9M | -48% | Mar 2024 |
|
| Alphabet | 209k | $6.3M | 0% | Mar 2024 |
|
| Susquehanna International | 206k | $6.2M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 190k | $5.7M | 100% | Mar 2024 |
|
| Atlas Venture Life Science Advisors | 187k | $5.6M | -21% | Mar 2024 |
|
| Goldman Sachs Group | 170k | $5.1M | 100% | Mar 2024 |
|
| Marshall Wace | 113k | $3.4M | 100% | Mar 2024 |
|
| Soleus Capital Management | 100k | $3.0M | 100% | Mar 2024 |
|
| Jane Street | 82k | $2.5M | 423% | Mar 2024 |
|
| Hudson Bay Capital Management | 80k | $2.4M | 100% | Mar 2024 |
|
| Geode Capital Management | 74k | $2.2M | 182% | Mar 2024 |
|
| Qube Research & Technologies | 68k | $2.0M | 2261433% | Mar 2024 |
|
| BlackRock | 47k | $1.4M | 45% | Mar 2024 |
|
| Two Sigma Investments | 38k | $1.1M | 100% | Mar 2024 |
|
| Pnc Financial Services | 37k | $1.1M | 100% | Mar 2024 |
|
| Fred Alger Management | 36k | $1.1M | -11% | Mar 2024 |
|
| Hrt Financial | 34k | $1.0M | 100% | Mar 2024 |
|
| Laurion Capital Management | 26k | $766k | -3% | Mar 2024 |
|
| Citadel Advisors | 25k | $745k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 24k | $724k | 100% | Mar 2024 |
|
| Citigroup | 23k | $682k | 31% | Mar 2024 |
|
| American Century Companies | 22k | $659k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 22k | $652k | 47% | Mar 2024 |
|
| Morgan Stanley | 21k | $633k | 13503% | Mar 2024 |
|
| Hussman Econometrics Advisors | 21k | $630k | 100% | Mar 2024 |
|
| Arrowpoint Asset Management | 21k | $624k | 0% | Mar 2024 |
|
| Northern Trust | 19k | $555k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 17k | $510k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 16k | $481k | 38968% | Mar 2024 |
|
| Bank of America Corporation | 16k | $465k | 275% | Mar 2024 |
|
| Bessemer | 15k | $154k | 0% | Dec 2023 |
|
| UBS Group | 15k | $435k | 3717% | Mar 2024 |
|
| Marathon Trading Investment Management | 15k | $435k | 100% | Mar 2024 |
|
| Barclays | 14k | $432k | 480000% | Mar 2024 |
|
| Squarepoint Ops | 14k | $409k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 13k | $401k | 100% | Mar 2024 |
|
| Virtu Financial | 13k | $390k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 12k | $368k | 100% | Mar 2024 |
|
| Y-Intercept | 12k | $363k | 100% | Mar 2024 |
|
| Rbf Capital | 11k | $324k | -31% | Mar 2024 |
|
| Point72 Asia | 10k | $310k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 8.4k | $253k | 100% | Mar 2024 |
|
| Engineers Gate Manager | 7.8k | $234k | 100% | Mar 2024 |
|
| Leucadia National Corporation | 7.6k | $228k | -42% | Mar 2024 |
|
| LMR Partners | 7.5k | $224k | 100% | Mar 2024 |
|
| XTX Topco | 7.2k | $217k | 100% | Mar 2024 |
|
| Polymer Capital Management | 6.7k | $201k | 100% | Mar 2024 |
|
| Acadian Asset Management | 4.0k | $120k | -82% | Mar 2024 |
|
| Tower Research Capital | 3.9k | $117k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 224.00 | $6.7k | 203% | Mar 2024 |
|
| Fernwood Investment Management | 102.00 | $3.1k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 81.00 | $2.0k | -76% | Mar 2024 |
|
| Institutional & Family Asset Management | 3.00 | $90.000000 | 0% | Mar 2024 |
|
Who sold out of Dianthus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nantahala Capital Management | Dec 2023 | 328k | $3.4M |
| ADAR1 Capital Management | Dec 2023 | 481.00 | $5.0k |